CENTESSA Trademark

Trademark Overview


On Monday, August 9, 2021, a trademark application was filed for CENTESSA with the United States Patent and Trademark Office. The USPTO has given the CENTESSA trademark a serial number of 90872691. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 17, 2024. This trademark is owned by Centessa Pharmaceuticals plc. The CENTESSA trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Downloadable and recorded software for drug delivery devices; downloadable and recorded software for administering and controlling drug delivery; downloadable and recorded software for use in medical and drug decision support; downloadable and recorded software for use in the acquisition, storage, sharing and analysis of medical data

Pharmaceutical products, preparations, and medicines for the treatment or prevention of hemophilia, tumors, hypertension, narcolepsy, inflammatory diseases or disorders, fibrotic diseases or disorders, autoimmune diseases or disorders, respiratory diseases or disorders, cardiovascular diseases or disorders, central nervous system diseases or disorders, immune system diseases or disorders, cancer, intractable diseases of liver, lung, and heart, and endocrinology diseases or disorders

Medical services; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical and pharmaceutical consultation and counseling services; treatments for orphan diseases of the kidney, including ADPKD (Autosomal dominant polycystic kidney disease); medical services, namely, providing medical therapies for hemophilia; medical services, namely, administration of pharmaceutical treatments for pulmonary arterial hypertension, oncological and autoimmune diseases; medical services, namely, providing medical treatments for narcolepsy; medical services, namely, providing medical treatments for skin disorders

Medical devices, namely, drug delivery devices and devices for delivering nasal spray treatments

Scientific and technological services and research in the medical and pharmaceutical field, namely, pharmaceutical product development; pharmaceutical research services; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Medical laboratories; Scientific and technological services and research and design relating thereto in the field of drug discovery; development of computer hardware and software
centessa

General Information


Serial Number90872691
Word MarkCENTESSA
Filing DateMonday, August 9, 2021
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements


Goods and ServicesDownloadable and recorded software for drug delivery devices; downloadable and recorded software for administering and controlling drug delivery; downloadable and recorded software for use in medical and drug decision support; downloadable and recorded software for use in the acquisition, storage, sharing and analysis of medical data
Goods and ServicesPharmaceutical products, preparations, and medicines for the treatment or prevention of hemophilia, tumors, hypertension, narcolepsy, inflammatory diseases or disorders, fibrotic diseases or disorders, autoimmune diseases or disorders, respiratory diseases or disorders, cardiovascular diseases or disorders, central nervous system diseases or disorders, immune system diseases or disorders, cancer, intractable diseases of liver, lung, and heart, and endocrinology diseases or disorders
Goods and ServicesMedical services; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical and pharmaceutical consultation and counseling services; treatments for orphan diseases of the kidney, including ADPKD (Autosomal dominant polycystic kidney disease); medical services, namely, providing medical therapies for hemophilia; medical services, namely, administration of pharmaceutical treatments for pulmonary arterial hypertension, oncological and autoimmune diseases; medical services, namely, providing medical treatments for narcolepsy; medical services, namely, providing medical treatments for skin disorders
Goods and ServicesMedical devices, namely, drug delivery devices and devices for delivering nasal spray treatments
Goods and ServicesScientific and technological services and research in the medical and pharmaceutical field, namely, pharmaceutical product development; pharmaceutical research services; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Medical laboratories; Scientific and technological services and research and design relating thereto in the field of drug discovery; development of computer hardware and software

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCentessa Pharmaceuticals plc
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCheshire WA142DT
GB

Party NameCentessa Pharmaceuticals plc
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCheshire WA142DT
GB

Trademark Events


Event DateEvent Description
Friday, June 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 12, 2021NEW APPLICATION ENTERED
Friday, October 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 9, 2022ASSIGNED TO EXAMINER
Friday, June 3, 2022NON-FINAL ACTION WRITTEN
Friday, June 3, 2022NON-FINAL ACTION E-MAILED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 9, 2023ASSIGNED TO LIE
Tuesday, January 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 28, 2023NON-FINAL ACTION WRITTEN
Friday, April 28, 2023NON-FINAL ACTION E-MAILED
Friday, April 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, June 28, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, June 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 3, 2024FINAL REFUSAL WRITTEN
Monday, June 3, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, June 3, 2024FINAL REFUSAL E-MAILED
Thursday, August 15, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, December 6, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, December 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 15, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, October 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 2, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, October 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED